{"id":"W6981310148","doi":"","title":"DREAMM-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma: Session: Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"PAGEPress (PAGEPress (Italy))","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pembrolizumab; Adverse effect; Multiple myeloma; Interim analysis; Safety profile; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001705463,0.0008592412,0.001633884,0.0002721087,0.000319175,0.000623667,0.0007233126,0.0009498264,0.006862049],"category_scores_gemma":[0.0009500834,0.0003590165,0.001536001,0.0002094964,0.0002136226,0.0004478321,0.0004283099,0.001936449,0.001297304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001139377,"about_ca_system_score_gemma":0.001323682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002532,"about_ca_topic_score_gemma":0.002460727,"domain_scores_codex":[0.9995111,0.0002307515,0.0000434416,0.00007486876,0.00007254993,0.00006725551],"domain_scores_gemma":[0.9992245,0.000132162,0.0001816954,0.00004101544,0.00007564599,0.0003449855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5788638,0.038252,0.02733998,0.002123111,0.003850717,0.000278907,0.0002923717,0.00509049,0.07234762,0.0002452066,0.02446517,0.2468506],"study_design_scores_gemma":[0.2282118,0.6581166,0.08020385,0.0001714117,0.001889274,0.0005395862,0.00007305911,0.003267176,0.01341317,0.0002986242,0.01375008,0.00006540433],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9753738,0.007099416,0.001018053,0.001567336,0.0002683389,0.00338081,0.005279819,0.0003065676,0.005705762],"genre_scores_gemma":[0.9784856,0.002301787,0.003102699,0.001153896,0.0002803056,0.002886034,0.005082104,0.00004028446,0.006667255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006862049,"threshold_uncertainty_score":0.02295583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04391471674687396,"score_gpt":0.2496703058719302,"score_spread":0.2057555891250563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}